Ifupinostat Hydrochloride for Injection

DRUG2 trials

Sponsors

BeBetter Med Inc

Conditions

Previously Untreated Peripheral T-Cell LymphomaRelapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 2

A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL)

Not yet recruitingNCT07676175

BeBetter Med IncPreviously Untreated Peripheral T-Cell Lymphoma

Start: 2026-07-01End: 2028-06-30Target: 120Updated: 2026-06-30

Phase 3

Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

RecruitingNCT06792253

BeBetter Med IncRelapsed/Refractory Diffuse Large B-Cell Lymphoma

Start: 2025-01-06End: 2029-06-30Target: 416Updated: 2025-01-24